<?xml version='1.0' encoding='UTF-8'?>

      <!-- iXBRL document created with: Toppan Merrill Bridge iXBRL 9.6.7713.40453 -->
      <!-- Based on: iXBRL 1.1 -->
      <!-- Created on: 5/12/2021 12:41:26 PM -->
      <!-- iXBRL Library version: 1.0.7713.40461 -->
      <!-- iXBRL Service Job ID: 097b0ade-3fff-464a-8d52-040cbd48f32d -->

  <html xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:sbbp="http://www.strongbridgebio.com/20210512" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrli="http://www.xbrl.org/2003/instance"><head><meta http-equiv="content-type" content="text/html" /><title></title></head><body><div style="margin-top:30pt;"></div><div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric contextRef="Duration_5_12_2021_To_5_12_2021_3h-VApo3bkmxPEP5JKBpNQ" name="dei:EntityCentralIndexKey" id="Tc_rXKwVFFrhEmjaGxUwDRyUg_2_1">0001634432</ix:nonNumeric><ix:nonNumeric contextRef="Duration_5_12_2021_To_5_12_2021_3h-VApo3bkmxPEP5JKBpNQ" name="dei:AmendmentFlag" id="Tc_V-U0v-MeKEyi4Luox8DV4Q_3_1">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="sbbp-20210512.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="Duration_5_12_2021_To_5_12_2021_3h-VApo3bkmxPEP5JKBpNQ"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001634432</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-12</xbrli:startDate><xbrli:endDate>2021-05-12</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;min-height:12.65pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:1pt;border-bottom:1.0pt solid #000000;border-top:3.0pt solid #000000;margin:0pt 6pt 0pt 6pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:5pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p><a id="_cf2c96ce_13a2_4375_b268_4aa2b81f0c40"></a><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:18pt;font-weight:bold;">UNITED STATES</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:18pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Washington, D.C. 20549</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:5pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p><div style="font-family:'Arial','Helvetica','sans-serif';font-size:11.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#848484;color:#848484;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:5pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:18pt;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">FORM </b><ix:nonNumeric contextRef="Duration_5_12_2021_To_5_12_2021_3h-VApo3bkmxPEP5JKBpNQ" name="dei:DocumentType" id="Narr_8R-pSN1TEkW_klkPgu_q-Q"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">8-K</b></ix:nonNumeric></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:5pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">CURRENT REPORT</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Pursuant to Section&#160;13 or 15(d)&#160;of The Securities Exchange Act of 1934</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:5pt;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">&#160;</b></p><div style="font-family:'Arial','Helvetica','sans-serif';font-size:11.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#848484;color:#848484;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">&#160;</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;text-align:center;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;">Date of Report (Date of earliest event reported):</span><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;"> </b><ix:nonNumeric contextRef="Duration_5_12_2021_To_5_12_2021_3h-VApo3bkmxPEP5JKBpNQ" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="Narr_Qpc2zM7Xa0iHvnpVsiXznQ"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;">May 12, 2021</b></ix:nonNumeric></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:5pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:18pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_12_2021_To_5_12_2021_3h-VApo3bkmxPEP5JKBpNQ" name="dei:EntityRegistrantName" id="Narr_qlnySr9BZEO-y8MQh2Tbaw"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">STRONGBRIDGE BIOPHARMA plc</b></ix:nonNumeric></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">(Exact name of registrant as specified in its charter)</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:5pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p><a id="_f88ef74f_83f8_4054_945e_9af12f57ba5a"></a><a id="Tc_jRm6OabEv0mwxlnRN_jBGw_2_0"></a><a id="Tc_xWSJZOhjPUahab7wM5z8-g_2_2"></a><a id="Tc_jhYXrAit4U-fr-P__U9P1g_2_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:bottom;width:1.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:top;width:31.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:bottom;width:1.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:top;width:31.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.26;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_12_2021_To_5_12_2021_3h-VApo3bkmxPEP5JKBpNQ" format="ixt-sec:edgarprovcountryen" name="dei:EntityIncorporationStateCountryCode" id="Tc_uDMu6sA0Ek-Yu91032oi3A_1_0"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;">Ireland</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.26;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p></td><td style="vertical-align:top;width:31.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.26;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_12_2021_To_5_12_2021_3h-VApo3bkmxPEP5JKBpNQ" name="dei:EntityFileNumber" id="Tc_yddAA9sWlk2YB4r0mK6vAg_1_2"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;">001-37569</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.26;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p></td><td style="vertical-align:top;width:31.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.26;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_12_2021_To_5_12_2021_3h-VApo3bkmxPEP5JKBpNQ" name="dei:EntityTaxIdentificationNumber" id="Tc_ca1lLzA450GF3Ch87yQ2aQ_1_4"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;">98-1275166</b></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:top;width:32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.26;text-align:center;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';"> (State or other<br />jurisdiction of incorporation)</span></p></td><td style="vertical-align:bottom;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.26;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p></td><td style="vertical-align:top;width:31.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.26;text-align:center;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';"> (Commission<br />File Number)</span></p></td><td style="vertical-align:bottom;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.26;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p></td><td style="vertical-align:top;width:31.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.26;text-align:center;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';"> (I.R.S. Employer<br />Identification No.)</span></p></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:5pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p><a id="_8116a9dc_3145_4720_b194_2b4235d6f40c"></a><a id="Tc_eU7pwtq1s0-n5ixewerShw_1_0"></a><a id="Tc_BC-z7LZI2kSOcp6OwCbM-w_2_0"></a><a id="Tc_9tYg6xhDqkWsUvPLHkyEzQ_2_2"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:bottom;width:1.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:48.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.26;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_12_2021_To_5_12_2021_3h-VApo3bkmxPEP5JKBpNQ" name="dei:EntityAddressAddressLine1" id="Narr_4hmFurR7BEObA0asK5zLeg"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;">900 Northbrook Drive</b></ix:nonNumeric><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;">, </b><ix:nonNumeric contextRef="Duration_5_12_2021_To_5_12_2021_3h-VApo3bkmxPEP5JKBpNQ" name="dei:EntityAddressAddressLine2" id="Narr_q-aV0VdrbEWsZE5yvtitUg"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;">Suite&#160;200</b></ix:nonNumeric><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;"><br /></span><ix:nonNumeric contextRef="Duration_5_12_2021_To_5_12_2021_3h-VApo3bkmxPEP5JKBpNQ" name="dei:EntityAddressCityOrTown" id="Narr_JoejtZUt9023mTV8h6SIyA"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;">Trevose</b></ix:nonNumeric><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;">, </b><ix:nonNumeric contextRef="Duration_5_12_2021_To_5_12_2021_3h-VApo3bkmxPEP5JKBpNQ" name="dei:EntityAddressStateOrProvince" id="Narr_J_CJNTmUoUqF2MVuwU0M0Q"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;">PA</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.26;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p></td><td style="vertical-align:bottom;width:48.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;line-height:1.26;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_12_2021_To_5_12_2021_3h-VApo3bkmxPEP5JKBpNQ" name="dei:EntityAddressPostalZipCode" id="Tc_ko0qKEnLFkaXR9JAuyAipg_1_2"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;">19053</b></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:top;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.26;text-align:center;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';"> (Address of principal executive offices)</span></p></td><td style="vertical-align:bottom;width:1.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.26;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p></td><td style="vertical-align:bottom;width:48.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.26;text-align:center;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';"> (Zip Code)</span></p></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:5pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;text-align:center;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;">Registrant&#8217;s telephone number, including area code:</span><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;"> (</b><ix:nonNumeric contextRef="Duration_5_12_2021_To_5_12_2021_3h-VApo3bkmxPEP5JKBpNQ" name="dei:CityAreaCode" id="Narr_VVse_hXps0eYg_E3lkdPMQ"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;">610</b></ix:nonNumeric><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;">) </b><ix:nonNumeric contextRef="Duration_5_12_2021_To_5_12_2021_3h-VApo3bkmxPEP5JKBpNQ" name="dei:LocalPhoneNumber" id="Narr_4ARPS__QKU6QMxnqIFYD0w"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;">254-9200</b></ix:nonNumeric></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p><div style="font-family:'Arial','Helvetica','sans-serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#848484;color:#848484;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto;"></div></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;text-align:justify;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_12_2021_To_5_12_2021_3h-VApo3bkmxPEP5JKBpNQ" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="Narr_5Owv4JybFkGtQ7Vc1rY7HA"><span style="font-family:'Segoe UI Symbol';font-size:10pt;">&#9744;</span></ix:nonNumeric><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;">&#160;&#160;Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;text-align:justify;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_12_2021_To_5_12_2021_3h-VApo3bkmxPEP5JKBpNQ" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="Narr_2J3dT5yxyEmgXvpNTQmxNA"><span style="font-family:'Segoe UI Symbol';font-size:10pt;">&#9744;</span></ix:nonNumeric><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;">&#160;&#160;Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;text-align:justify;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_12_2021_To_5_12_2021_3h-VApo3bkmxPEP5JKBpNQ" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="Narr_HA2wxBqHZEKXZ9SpZXroyQ"><span style="font-family:'Segoe UI Symbol';font-size:10pt;">&#9744;</span></ix:nonNumeric><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;">&#160;&#160;Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;text-align:justify;margin:0pt;"><ix:nonNumeric contextRef="Duration_5_12_2021_To_5_12_2021_3h-VApo3bkmxPEP5JKBpNQ" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="Narr_u46Z_qRT_ka-b-X46Alxfg"><span style="font-family:'Segoe UI Symbol';font-size:10pt;">&#9744;</span></ix:nonNumeric><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;">&#160;&#160;Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p><a id="_220fbba9_842f_476f_9865_82102c56776e"></a><div style="margin-left:0pt;"><a id="Tc_x7k1xeXLBEWedYZnr3NWgw_1_0"></a><a id="Tc_hHS1Lr3IIkiYFrI3Nf3Ctg_2_0"></a><a id="Tc_-XnDMkLBh0GCyiD8u7Pdgg_2_2"></a><a id="Tc_S5iUVrn8sEiBCHSJC1206A_2_4"></a><a id="Tc_5aW3SpVRZE6MPEyyyFDo3A_3_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:31.75%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:2.86%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:20.22%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;width:2.89%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:42.26%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td colspan="5" style="vertical-align:top;width:100%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 6pt 5.5pt;"><span style="font-family:'Times New Roman','Times','serif';">Securities Registered Pursuant to Section 12(b) of the Act:</span></p></td></tr><tr><td style="vertical-align:bottom;width:31.75%;border-bottom:1.5pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt 0pt 0pt 5.5pt;"><span style="font-family:'Times New Roman','Times','serif';">Title of each class</span></p></td><td style="vertical-align:bottom;width:2.86%;border-bottom:1.5pt solid transparent;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:center;margin:0pt 0pt 0pt 5.5pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:20.22%;border-bottom:1.5pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt 0pt 0pt 5.5pt;"><span style="font-family:'Times New Roman','Times','serif';">Trading Symbol(s)</span></p></td><td style="vertical-align:bottom;width:2.89%;border-bottom:1.5pt solid transparent;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:center;margin:0pt 0pt 0pt 5.5pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:42.26%;border-bottom:1.5pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Name of each exchange on which registered</span></p></td></tr><tr><td style="vertical-align:top;width:31.75%;border-top:1.5pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:center;margin:0pt 0pt 0pt 5.5pt;"><ix:nonNumeric contextRef="Duration_5_12_2021_To_5_12_2021_3h-VApo3bkmxPEP5JKBpNQ" name="dei:Security12bTitle" id="Tc__xcLOv2LKUWfFmiFNFkMag_3_0"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;">Ordinary shares, par value $0.01 per share</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:2.86%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:center;margin:0pt 0pt 0pt 5.5pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:20.22%;border-top:1.5pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:center;margin:0pt 0pt 0pt 5.5pt;"><ix:nonNumeric contextRef="Duration_5_12_2021_To_5_12_2021_3h-VApo3bkmxPEP5JKBpNQ" name="dei:TradingSymbol" id="Tc_OhLUOvijDkGf9fx8yg5csQ_3_2"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;">SBBP</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:2.89%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:center;margin:0pt 0pt 0pt 5.5pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:42.26%;border-top:1.5pt solid #000000;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;text-align:center;margin:0pt 0pt 0pt 5.5pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;">The </span><ix:nonNumeric contextRef="Duration_5_12_2021_To_5_12_2021_3h-VApo3bkmxPEP5JKBpNQ" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="Narr_tK1WvJxaWUuKdX4MgKMlBg"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;">Nasdaq</span></ix:nonNumeric><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;"> Global Select Market</span></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:7pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule&#160;405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule&#160;12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).&#160;</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;text-align:right;text-indent:216pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;">Emerging growth company&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span><ix:nonNumeric contextRef="Duration_5_12_2021_To_5_12_2021_3h-VApo3bkmxPEP5JKBpNQ" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="Narr_TCKpP2NpXkKwV7eewvcuBA"><span style="font-family:'Segoe UI Symbol';font-size:10pt;">&#9744;</span></ix:nonNumeric></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:5pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act. </span><span style="font-family:'Segoe UI Symbol';">&#9744;</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:6pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:1pt;border-bottom:3.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt 6pt 0pt 6pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p><p style="display:none;line-height:0pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:0pt;visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:76.47%;border:0;margin:30pt 11.76% 30pt 11.76%;"></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><a id="part_1_2_1"></a><a id="item_1_26_1"></a><a id="_Hlk8318347"></a><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:2pt;visibility:hidden;">&#8203;</span></p><a id="_66112348_152e_4f8b_b06d_2830995e1441"></a><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;white-space:pre-wrap;">Item 2.02              Results of Operations and Financial Condition.</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">On May 12, 2021, Strongbridge Biopharma plc (the &#8220;Company&#8221;) issued a press release reporting first quarter financial results and providing a corporate update. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1.</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The information contained in Item 2.02 of this Current Report on Form 8-K and Exhibit 99.1 is being furnished to the Commission and shall not be deemed &#8220;filed&#8221; for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section. The information in Exhibit 99.1 shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), except as expressly set forth by specific reference in such filing. The information set forth herein will not be deemed an admission as to the materiality of any information required to be disclosed solely to satisfy the requirements of Regulation FD.</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:72pt;"><b style="color:#000000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;text-align:left;">Item 7.01</b></span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Regulation FD Disclosure.</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">The response to Item 2.02 is incorporated herein by reference to this Item 7.01.</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="display:inline-block;text-indent:0pt;width:72pt;"><b style="color:#000000;font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;text-align:left;">Item 9.01</b></span><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Financial Statements and Exhibits.</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;white-space:pre-wrap;">(d)   Exhibits</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:10%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:86.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:10%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Exhibit<br />Number</b></p></td><td style="vertical-align:bottom;width:3%;border-bottom:1px solid transparent;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;text-align:center;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:86.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Exhibit&#160;Table</b></p></td></tr><tr><td style="vertical-align:top;width:10%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:86.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:10%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 6pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">99.1 </span></p></td><td style="vertical-align:bottom;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;margin:0pt 0pt 6pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:86.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;margin:0pt 0pt 6pt 0pt;"><a style="-sec-extract:exhibit;" href="sbbp-20210512xex99d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Press Release issued by Strongbridge Biopharma plc, dated May 12, 2021.</span></a></p></td></tr><tr><td style="vertical-align:top;width:10%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 6pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">104</span></p></td><td style="vertical-align:bottom;width:3%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;margin:0pt 0pt 6pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:86.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 6pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Cover Page Interactive Data File (formatted as inline XBRL)</span></p></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:76.47%;border:0;margin:30pt 11.76% 30pt 11.76%;"></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">SIGNATURES</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 18pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:50.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:6.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:43.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:50.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:1pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p></td><td colspan="2" style="vertical-align:top;width:49.15%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">STRONGBRIDGE BIOPHARMA PLC</b></p></td></tr><tr><td style="vertical-align:top;width:50.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p></td><td colspan="2" style="vertical-align:top;width:49.15%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p></td></tr><tr><td style="vertical-align:top;width:50.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:1pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p></td><td style="vertical-align:top;width:6.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">By:</span></p></td><td style="vertical-align:top;width:43.07%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">/s/ Richard Kollender</span></p></td></tr><tr><td style="vertical-align:top;width:50.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:1pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p></td><td style="vertical-align:top;width:6.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Name:</span></p></td><td style="vertical-align:top;width:43.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Richard Kollender</span></p></td></tr><tr><td style="vertical-align:top;width:50.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:1pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p></td><td style="vertical-align:top;width:6.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Title: </span></p></td><td style="vertical-align:top;width:43.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">President, Chief Financial Officer</span></p></td></tr><tr><td style="vertical-align:top;width:50.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p></td><td colspan="2" style="vertical-align:top;width:49.15%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p></td></tr><tr><td style="vertical-align:top;width:50.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:12pt 0pt 0pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Date: May 12, 2021</span></p></td><td colspan="2" style="vertical-align:top;width:49.15%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:1pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:1pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:avoid;width:76.47%;border:0;"></div></body></html>
[{"type": "8-K", "sequence": "1", "filename": "sbbp-20210512x8k.htm", "description": "8-K", "secsgml_size_bytes": 48538}]
{"company-data": {"conformed-name": "Strongbridge Biopharma plc", "cik": "0001634432", "assigned-sic": "2834", "irs-number": "981130690", "state-of-incorporation": "L2"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-37569", "film-number": "21913590"}, "business-address": {"street1": "900 NORTHBROOK DRIVE, SUITE 200", "city": "TREVOSE", "state": "PA", "zip": "19053", "phone": "(610) 254-9200"}, "mail-address": {"street1": "900 NORTHBROOK DRIVE, SUITE 200", "city": "TREVOSE", "state": "PA", "zip": "19053"}, "former-company": {"former-conformed-name": "Cortendo AB", "date-changed": "20150219"}}
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
May 12, 2021
STRONGBRIDGE BIOPHARMA plc
(Exact name of registrant as specified in its charter)
Ireland
001-37569
98-1275166
(State or other
jurisdiction of incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
​
900 Northbrook Drive
,
Suite 200
Trevose
,
PA
19053
(Address of principal executive offices)
(Zip Code)
Registrant's telephone number, including area code:
(
610
)
254-9200
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
​
​
Securities Registered Pursuant to Section 12(b) of the Act:
Title of each class
​
Trading Symbol(s)
​
Name of each exchange on which registered
Ordinary shares, par value $0.01 per share
​
SBBP
​
The
Nasdaq
Global Select Market
​
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
​
Item 2.02              Results of Operations and Financial Condition.
​
On May 12, 2021, Strongbridge Biopharma plc (the "Company") issued a press release reporting first quarter financial results and providing a corporate update. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1.
​
The information contained in Item 2.02 of this Current Report on Form 8-K and Exhibit 99.1 is being furnished to the Commission and shall not be deemed "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section. The information in Exhibit 99.1 shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended (the "Securities Act"), except as expressly set forth by specific reference in such filing. The information set forth herein will not be deemed an admission as to the materiality of any information required to be disclosed solely to satisfy the requirements of Regulation FD.
​
Item 7.01
Regulation FD Disclosure.
​
The response to Item 2.02 is incorporated herein by reference to this Item 7.01.
​
Item 9.01
Financial Statements and Exhibits.
​
(d)   Exhibits
​
​
​
​
Exhibit
Number
​
Exhibit Table
​
​
​
99.1
​
Press Release issued by Strongbridge Biopharma plc, dated May 12, 2021.
104
​
Cover Page Interactive Data File (formatted as inline XBRL)
​
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
​
​
​
STRONGBRIDGE BIOPHARMA PLC
By:
/s/ Richard Kollender
Name:
Richard Kollender
Title:
President, Chief Financial Officer
Date: May 12, 2021
​
​
​
​